X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Aurobindo Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs AUROBINDO PHARMA - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS AUROBINDO PHARMA J.B.CHEMICALS/
AUROBINDO PHARMA
 
P/E (TTM) x 16.6 14.9 112.1% View Chart
P/BV x 2.1 3.0 70.0% View Chart
Dividend Yield % 0.6 0.4 134.2%  

Financials

 J.B.CHEMICALS   AUROBINDO PHARMA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
AUROBINDO PHARMA
Mar-18
J.B.CHEMICALS/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs363809 44.9%   
Low Rs255504 50.6%   
Sales per share (Unadj.) Rs169.1281.1 60.2%  
Earnings per share (Unadj.) Rs16.641.4 40.1%  
Cash flow per share (Unadj.) Rs23.450.9 46.0%  
Dividends per share (Unadj.) Rs2.002.50 80.0%  
Dividend yield (eoy) %0.60.4 169.9%  
Book value per share (Unadj.) Rs172.5199.4 86.5%  
Shares outstanding (eoy) m83.57585.88 14.3%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x1.82.3 78.2%   
Avg P/E ratio x18.615.9 117.3%  
P/CF ratio (eoy) x13.212.9 102.3%  
Price / Book Value ratio x1.83.3 54.4%  
Dividend payout %12.06.0 199.3%   
Avg Mkt Cap Rs m25,827384,630 6.7%   
No. of employees `0003.817.3 21.8%   
Total wages/salary Rs m2,51121,308 11.8%   
Avg. sales/employee Rs Th3,747.49,500.7 39.4%   
Avg. wages/employee Rs Th665.71,229.4 54.1%   
Avg. net profit/employee Rs Th367.81,397.9 26.3%   
INCOME DATA
Net Sales Rs m14,135164,666 8.6%  
Other income Rs m3661,020 35.9%   
Total revenues Rs m14,501165,686 8.8%   
Gross profit Rs m2,17837,718 5.8%  
Depreciation Rs m5705,580 10.2%   
Interest Rs m35777 4.5%   
Profit before tax Rs m1,94032,380 6.0%   
Minority Interest Rs m031 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5528,183 6.7%   
Profit after tax Rs m1,38724,229 5.7%  
Gross profit margin %15.422.9 67.3%  
Effective tax rate %28.525.3 112.7%   
Net profit margin %9.814.7 66.7%  
BALANCE SHEET DATA
Current assets Rs m10,470121,878 8.6%   
Current liabilities Rs m2,74986,806 3.2%   
Net working cap to sales %54.621.3 256.5%  
Current ratio x3.81.4 271.3%  
Inventory Days Days55130 42.5%  
Debtors Days Days7868 113.6%  
Net fixed assets Rs m5,81181,037 7.2%   
Share capital Rs m167586 28.5%   
"Free" reserves Rs m14,248116,218 12.3%   
Net worth Rs m14,416116,804 12.3%   
Long term debt Rs m04,512 0.0%   
Total assets Rs m17,649211,052 8.4%  
Interest coverage x56.642.7 132.6%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.8 102.7%   
Return on assets %8.111.8 68.0%  
Return on equity %9.620.7 46.4%  
Return on capital %13.727.4 50.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m6,16480,727 7.6%   
Fx outflow Rs m1,33434,700 3.8%   
Net fx Rs m4,82946,027 10.5%   
CASH FLOW
From Operations Rs m1,23119,548 6.3%  
From Investments Rs m-208-19,570 1.1%  
From Financial Activity Rs m-5958,642 -6.9%  
Net Cashflow Rs m4278,922 4.8%  

Share Holding

Indian Promoters % 55.4 54.1 102.4%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 8.0 42.6%  
FIIs % 3.9 27.7 14.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 10.2 362.7%  
Shareholders   30,437 69,601 43.7%  
Pledged promoter(s) holding % 0.0 8.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   SUVEN LIFESCIENCES  SHASUN PHARMA  PFIZER  GLENMARK PHARMA  ORCHID PHARMA LTD  

Compare J.B.CHEMICALS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Over 300 Points Higher; Energy and Metal Stocks Witness Buying(Closing)

After opening the day marginally lower, Indian share markets witnessed most of the buying interest during closing hours and ended their trading session on a strong note.

Related Views on News

AUROBINDO PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 10.9% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, AUROBINDO PHARMA has posted a net profit of Rs 6 bn (up 10.9% YoY). Sales on the other hand came in at Rs 53 bn (up 30.7% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

AUROBINDO PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 19.3% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, AUROBINDO PHARMA has posted a net profit of Rs 7 bn (up 19.3% YoY). Sales on the other hand came in at Rs 53 bn (up 21.5% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of AUROBINDO PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

More Views on News

Most Popular

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

Kenneth Andrade Would Like Our Real Estate Stock Recommendation with Triple Digit Upside(The 5 Minute Wrapup)

Jun 12, 2019

This real estate stock recommended in Smart Money Secrets offers the most favourable upside potential.

Why I Believe Smallcaps Will Catch up to the Sensex(Profit Hunter)

Jun 14, 2019

Smallcaps have gone nowhere even as the Sensex makes new all-time highs. Find out why Richa believes this a good opportunity to invest in smallcaps.

Why Super Investor Kenneth Andrade is Bullish on Agri Stocks...and So Are We(The 5 Minute Wrapup)

Jun 21, 2019

Andrade gives his take on agriculture, an industry from which we have already recommended two stocks.

7 Bluechips to Profit from Tech Disruption(Profit Hunter)

Jun 17, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Jun 25, 2019 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - ASTRAZENECA PHARMA COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS